| Literature DB >> 35547645 |
Zabihulah Abid1, Rafael Castro Delgado1, José Antonio Cernuda Martinez1, Pedro Arcos González1.
Abstract
Background: The COVID-19 pandemic, declared by the World Health Organization as a public health international emergency concern in March 2020, has caused serious impacts on individuals, families, communities, and societies across the globe. The COVID-19 pandemic not only disrupted the health systems and the economy, but also significantly impacted routine immunization programs. Aim: To study the impact of the COVID-19 pandemic lockdown on the routine immunization coverage program in the province of Laghman, Afghanistan.Entities:
Keywords: COVID-19; children; lockdown; pandemics; vaccination
Year: 2022 PMID: 35547645 PMCID: PMC9084504 DOI: 10.2147/RMHP.S352567
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Figure 1Comparison of total doses of vaccines used by each district during April–July 2020 vs April–July 2019.
Illustrate Comparison of Vaccine Utilization by Types of Antigens and Total Decline During April–July 2020 vs April–July 2019
| Data Elements | Comparison Period (April–July 2019) | Study Period (April–July 2020) | Diff % (April–July 2020 vs 2019) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed | Outreach | Total | Fixed | Outreach | Total | Fixed (%) | Outreach (%) | Total (%) | ||
| BCG | 11,784 | 2,171 | 13,955 | 10,544 | 814 | 11,358 | −11% | −63% | −19% | |
| HepB | 7,087 | 56 | 7,143 | 6,678 | 11 | 6,689 | −6% | −80% | −6% | |
| IPV | 9,434 | 2,426 | 11,860 | 8,030 | 1,131 | 9,161 | −15% | −53% | −23% | |
| Meas/MR1 | 7,379 | 2,451 | 9,830 | 6,051 | 982 | 7,033 | −18% | −60% | −28% | |
| OPV-0 | 9,134 | 814 | 9,948 | 8,023 | 123 | 8,146 | −12% | −85% | −18% | |
| OPV-1 | 9,825 | 2,404 | 12,229 | 8,806 | 1,053 | 9,859 | −10% | −56% | −19% | |
| OPV-2 | 8,941 | 2,247 | 11,188 | 7,701 | 1,077 | 8,778 | −14% | −52% | −22% | |
| OPV-3 | 9,434 | 2,426 | 11,860 | 8,030 | 1,131 | 9,161 | −15% | −53% | −23% | |
| OPV-4 | 6,017 | 1,777 | 7,794 | 4,894 | 701 | 5,595 | −19% | −61% | −28% | |
| PCV-1 | 9,057 | 2,223 | 11,280 | 7,879 | 985 | 8,864 | −13% | −56% | −21% | |
| PCV-2 | 8,098 | 2,096 | 10,194 | 6,856 | 1,011 | 7,867 | −15% | −52% | −23% | |
| PCV-3 | 8,418 | 2,177 | 10,595 | 6,814 | 1,013 | 7,827 | −19% | −53% | −26% | |
| Penta-1 | 9,825 | 2,404 | 12,229 | 8,793 | 1,066 | 9,859 | −11% | −56% | −19% | |
| Penta-2 | 8,941 | 2,247 | 11,188 | 7,701 | 1,077 | 8,778 | −14% | −52% | −22% | |
| Penta-3 | 9,434 | 2,426 | 11,860 | 8,029 | 1,132 | 9,161 | −15% | −53% | −23% | |
| Rota-1 | 9,287 | 2,281 | 11,568 | 8,285 | 985 | 9,270 | −11% | −57% | −20% | |
| Rota-2 | 8,090 | 2,085 | 10,175 | 6,928 | 953 | 7,881 | −14% | −54% | −23% | |
Illustrate Changes of Vaccination Utilization by Gender (Girls, Boys) vs Fixed and Outreach During the Study and Comparison Period
| Gender | Comparison Period (April–July 2019) | Total | Study Period (April–July 2020) | Total | Diff in Percentage | ||||
|---|---|---|---|---|---|---|---|---|---|
| Fixed | Outreach | Fixed | Outreach | Fixed % | Outreach % | ||||
| Boys | 75,801 | 17,615 | 69,321 | 7,909 | −9% | −55% | 0.115 | ||
| Girls | 74,384 | 17,096 | 60,721 | 7,336 | −18% | −57% | |||
| 150,185 | 34,711 | 130,042 | 15,245 | ||||||